* Humanigen Inc HGEN.OQ reported quarterly adjusted
earnings of
5 cents per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 6 cents per share.
* Revenue fell 78.7% to $221.00 thousand from a year ago;
analysts
expected $100.00 thousand.
* Humanigen Inc's reported EPS for the quarter was 5 cents.
* The mean earnings estimate of analysts had fallen by
about 63.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Humanigen Inc shares had fallen by 2.4% this quarter and
gained 16.7% so far this year.
* The company reported quarterly net income of $4.39
million.
* Wall Street's median 12-month price target for Humanigen
Inc is
$0.33
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
April 4 at 06:35 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.06 0.05 Beat
Sep. 30 2022 -0.18 -0.23 Missed
Jun. 30 2022 -0.30 -0.43 Missed
Mar. 31 2022 -0.46 -0.32 Beat